Olaf Heidenreich received a PhD degree from the University of Göttingen. During this time he worked on catalytic RNAs with Fritz Eckstein at the Max Planck Institute for Experimental Medicine. After a postdoc at the Scripps Research Institute in La Jolla, California, he was e a senior research associate at the Medical School Hannover and a lecturer at the University of Tübingen. In 2007, he joined the Northern Institute for Cancer Research at Newcastle University as a Senior Lecturer and became a Professor of Molecular Haematology in 2012. In 2018, he joined the Princess Máxima Center as senior PI. His research interests focus on leukaemic fusion genes, their impact on malignant self-renewal and their exploitation as cancer-specific therapeutic targets.